2026 Legislative Conference
During APMA's Legislative Conference, more than 100 podiatrists met with elected officials and congressional staff to address critical issues facing the profession, especially the burden of outdated Medicare and Medicaid policies. The recently introduced Diabetes Foot Health Access and Modernization Act took center stage, driving conversations in more than 200 meetings with congressional offices, including 25 directly with members of Congress.
Read More
Prior Authorization Expansion
APMA called on CMS to reverse its decision to require prior authorization for HCPCS code L1932—an ankle-foot orthosis essential for treating conditions that impact mobility and function. APMA warns that this requirement could delay access to medically necessary care and negatively affect patient outcomes, particularly for those with ambulatory challenges.
Read More
OIG Alert on Modifier 25
HHS Office of Inspector General (OIG) added a new Work Plan project which will examine evaluation and management (E/M) services billed on the same day as minor surgical procedures without modifier 25.
Read More
CMS Coverage Policies
APMA participated in a CAC Engagement Coalition meeting with CMS staff and coalition partners, to discuss ongoing efforts to strengthen engagement with the Medicare LCD process. APMA’s continued engagement is an important part of its larger strategy to ensure podiatrists’ expertise is represented in coverage policy discussions.
Read More
Imaging Interoperability
APMA responded to a Department of Health & Human Services’ “Request for Information: Diagnostic Imaging Interoperability Standards and Certification,” expressing strong support for improving standards for imaging interoperability.
Read More
New APMA Resources on Wound Care Documentation
APMA has two new resources to help with wound care documentation: a webinar hosted by APMA RUC Advisor, Susan Walsh, DPM, MBA, and an article in APMA News from Coding Committee member Jonathon Huey, DPM, and Dr. Walsh.
Read More
APMA Pushes for Changes to NPUECM
APMA has submitted a letter to Acumen and CMS regarding the development of the Non-Pressure Ulcer Episode-Based Cost Measure (NPUECM) and requested a meeting to advocate for podiatrists.
Read More
AMA National Advocacy Conference
APMA staff participated in the AMA National Advocacy Conference that focused on how to advance shared legislative priorities, including meaningful Medicare Physician Payment Reform, reducing administrative burdens caused by prior authorization, and protecting and strengthening access to Medicaid. Following policy briefings from members of Congress, CMS officials, and national health-care leaders, APMA staff took these priorities directly to meetings on Capitol Hill.
Read More
Alliance Advocacy Impact Report
APMA’s advocacy impact is strengthened through active participation in the Alliance of Wound Care Stakeholders (Alliance). We are proud to share the Alliance’s 2025 Advocacy Impact Report, which highlights the collective progress made to advance fair reimbursement, appropriate coverage, and equitable patient access.
Read More
APMA Position Statement on AI
APMA adopted a formal position statement on artificial intelligence (AI) and submitted comments to HHS in response to its national Request for Information on the use of AI in clinical care. APMA emphasized that AI should support, not replace, physician judgment. We also raised concerns that opaque algorithms and broad datasets can lead to inappropriate denials, downcoding, and delays in patient care.
Read More
APMA Supports State Legislative Efforts
APMA continues to work closely with state components on legislative strategy, stakeholder engagement, testimony development, grassroots advocacy, and regulatory outreach across multiple states, including Tennessee, Massachusetts, and Mississippi. Several states are also actively considering adoption of the IPMLC, including Arizona, Florida, Iowa, Maryland, and Ohio.
Read More
DME Enrollment Moratorium
Last week, CMS announced a moratorium on enrollment (and enrollment expansion) for certain medical supply companies. This enrollment moratorium affects medical supply companies whose principal function is to furnish DMEPOS supplies, which does not represent most physician suppliers.
Read More
